B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Moura, R. A. [1 ]
Quaresma, C. [1 ]
Vieira, A. R. [1 ]
Goncalves, M. J. [1 ,2 ]
Polido-Pereira, J. [1 ,2 ]
Romao, V. [1 ,2 ]
Martins, N. [2 ]
Canhao, H. [1 ,2 ]
Fonseca, J. E. [1 ,2 ]
机构：
[1] Hosp Santa Maria, EPE, Lisbon Acad Med Ctr, Ctr Hosp Lisboa Norte,Rheumatol Res Unit,Inst Med, Lisbon, Portugal
[2] Hosp Santa Maria, EPE, Lisbon Acad Med Ctr, Ctr Hosp Lisboa Norte,Rheumatol Dept, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0024
引用
收藏
页码：905 / 905
页数：1
相关论文
共 50 条
  • [21] CHANGES IN THE MIRNA REPERTOIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH TNF-INHIBITORS
    Wielinska, Joanna
    Crossland, Rachel E.
    Lacina, Piotr
    Swierkot, Jerzy
    Bugaj, Bartosz
    Dickinson, Anne
    Bogunia-Kubik, Katarzyna
    HLA, 2020, 95 (04) : 364 - 365
  • [22] SEVERE EXTRA-ARTICULAR MANIFESTATIONS IN RHEUMATOID ARTHRITIS: RISK FACTORS AND INCIDENCE IN RELATION TO TREATMENT WITH TNF-INHIBITORS
    Theander, L.
    Wahlin, B. -M. Nyhall
    Nilsson, J. -A.
    Jacobsson, L.
    Geborek, P.
    Petersson, I. F.
    Turesson, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 424 - 424
  • [23] B-cell: a logical target for treatment of rheumatoid arthritis
    Youinou, P.
    Jamin, C.
    Saraux, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 318 - 328
  • [24] Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker
    Usuba, Fany Solange
    de Medeiros-Ribeiro, Ana Cristina
    Novaes, Priscila
    Aikawa, Nadia Emi
    Bonfiglioli, Karina
    Santo, Ruth Miyuki
    Bonfa, Eloisa
    Alves, Milton Ruiz
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] O32 Serious infection with tocilizumab compared to TNF-inhibitors and other bDMARDS in rheumatoid arthritis patients: does line of therapy matter?
    Lauper, Kim
    Kearsley-Fleet, Lianne
    Davies, Rebecca
    Watson, Kath
    Lunt, Mark
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2021, 60
  • [26] Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker
    Fany Solange Usuba
    Ana Cristina de Medeiros-Ribeiro
    Priscila Novaes
    Nadia Emi Aikawa
    Karina Bonfiglioli
    Ruth Miyuki Santo
    Eloisa Bonfá
    Milton Ruiz Alves
    Scientific Reports, 10
  • [27] THE BLOOD B-CELL SUBSETS AND EFFECT OF TOCILIZUMAB THERAPY ON THEM IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Gerasimova, E.
    Popkova, T.
    Aleksankin, A.
    Davidyan, S.
    Martinova, A.
    Aleksandrova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 950 - 951
  • [28] EFFECTS OF TNF-INHIBITORS (INFLIXIMAB) ON CD147 EXPRESSION AND MMP-3 LEVEL IN RHEUMATOID ARTHRITIS PATIENTS
    Wu, Z.
    Jia, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 490 - 490
  • [29] Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
    Lauper, Kim
    Mongin, Denis
    Bergstra, Sytske Anne
    Choquette, Denis
    Codreanu, Catalin
    Gottenberg, Jacques-Eric
    Kubo, Satoshi
    Hetland, Merete Lund
    Iannone, Florenzo
    Kristianslund, Eirik K.
    Kvien, Tore K.
    Lukina, Galina
    Mariette, Xavier
    Nordstrom, Dan C.
    Pavelka, Karel
    Pombo-Suarez, Manuel
    Rotar, Ziga
    Santos, Maria J.
    Tanaka, Yoshiya
    Turesson, Carl
    Courvoisier, Delphine S.
    Finckh, Axel
    Gabay, Cem
    JOINT BONE SPINE, 2024, 91 (02)
  • [30] Peripheral Blood Gene Expression and IgG Glycosylation Profiles as Markers of Tocilizumab Treatment in Rheumatoid Arthritis
    Mesko, Bertalan
    Poliska, Szilard
    Szamosi, Szilvia
    Szekanecz, Zoltan
    Podani, Janos
    Varadi, Csaba
    Guttman, Andras
    Nagy, Laszlo
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (05) : 916 - 928
12345